Apollo Hospitals Enterprise Ltd dividend

The Dividend per Share of Apollo Hospitals Enterprise Ltd is ₹ 15 as of 2023 .a1#The Dividend Payout of Apollo Hospitals Enterprise Ltd changed from 27.58 % on March 2019 to 19.88 % on March 2023 . This represents a CAGR of -6.34% over 5 years. a1#The Latest Trading Price of Apollo Hospitals Enterprise Ltd is ₹ 6388 as of 25 Jul 15:30 .a1#The Market Cap of Apollo Hospitals Enterprise Ltd changed from ₹ 16986 crore on March 2019 to ₹ 61962 crore on March 2023 . This represents a CAGR of 29.54% over 5 years. a1#The Revenue of Apollo Hospitals Enterprise Ltd changed from ₹ 3811 crore to ₹ 4980 crore over 8 quarters. This represents a CAGR of 14.31% a1#The EBITDA of Apollo Hospitals Enterprise Ltd changed from ₹ 494.9 crore to ₹ 677.2 crore over 8 quarters. This represents a CAGR of 16.98% a1#The Net Pr of Apollo Hospitals Enterprise Ltd changed from ₹ 323.9 crore to ₹ 258.4 crore over 8 quarters. This represents a CAGR of -10.68% a1#

It has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics. Apart from the hospital activities, The Apollo School of nursing was commissioned in August of the year1991, which offers a 3-year diploma programme followed by internship in the hospital. Further, AHEL had introduced state-of-the-art Bone Marrow transplant facility in Phase II expansion of cancer project. As at 19th February of the year 1995, another one wing was added, Cancer hospital in Hyderabad was inaugurated. AHEL had signed a memorandum of understanding with Jardine of UK for successful adaptation of the health maintenance organisations (HMO) in the year 1997, a concept for the first time in India. A year after, in 1998, also signed a memorandum of understanding with the Sri Lankan Government to build a super-speciality hospital in Colombo. In the same year AHEL had launched a personal accident insurance card and commissioned the Italian Dental Clinic. And also in the same year, it made a partnership to provide advisory services to Hayel Saeed Anam (HSA) group, Yemen. The acquisition would be in the form of purchase of the business undertaking, on a slump sale basis and comprises of 320 pharmacy stores, at an overall consideration not exceeding Rs 146 crore. Correspondingly, Munich Re's shareholding in Apollo Munich shall increase to 48.7% and 0.2% stake will be held by employees. AHLL is engaged in retail healthcare business encompassing primary health clinics, birthing centres, dental & dialysis centres, day surgery centres and sugar clinics. The Company had reduced its equity stake to 40% from 100% in Apollo Healthcare Technology Solutions Limited (AHTSL) on 23rd January 2017. As on 31st March 2019, the Company had nineteen direct subsidiaries, ten step down subsidiaries, four joint ventures and four associate companies. In accordance with Section 230 of the Companies Act, the Company filed the NCLT order with the Ministry of Company Affairs (Registrar of Companies) on September 1, 2020. On 07 January 2021, the company acquired 1% additional stake in Medics International Life Sciences Limited, a Joint Venture,which runs a 330-bedded hospital in Lucknow.